Summary

This Beiersdorf AG Company Profile offers detailed strategic analysis of the company's business, examining its performance in the OTC healthcare industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.

Content

Beiersdorf AG (OTC Healthcare)

Strategic Evaluation

Swot analysis
Strengths Weaknesses Opportunities Threats Prospects for The OTC Healthcare Business
Slow growth forecast, especially in Beiersdorf''s key sectors Consolidation makes competitors fewer but bigger Nivea brand leads Beiersdorf''s increasing focus on skin care Beiersdorf to remain strong in Western Europe North America remains unwelcoming, focus turns to Latin nations Eucerin makes a play for Asian markets Major acquisitions looking unlikely

Table 1 Beiersdorf AG: World Sector Sales Performance by Value 2005

Table 2 Beiersdorf AG: OTC Healthcare Regional Sales Performance by Value 2005

Corporate Overview

Strategic Objectives and Challenges
Operational and Distribution Strategies
Ownership Events
Pipeline

Summary 1 Beiersdorf AG: Key Facts by Value

Performance by Region and by Sector

OTC Healthcare Market Assessment
Limited involvement in the industry Western Europe is Beiersdorf''s key market Involvement in North American and Asia Pacific markets declining Beiersdorf failing to capitalise on increasing value of the Latin American market Wound Treatments
Competitive landscape Prospects Medicated Skin Care
Competitive landscape Prospects

Table 3 Beiersdorf AG: World Shares & Rankings in OTC Healthcare by Sector by Value 2004- 2005

Table 4 Beiersdorf AG: World and Regional Shares in OTC Healthcare by Sector by Value 2005

Brand Assessment

Brand Strategy
Eucerin
Hansaplast

Table 5 Beiersdorf AG: Eucerin Brand Shares in OTC Healthcare by Sector by Value 2004-2005

Table 6 Beiersdorf AG: Eucerin Regional Shares in OTC Healthcare by Sector by Value 2005

Table 7 Beiersdorf AG: Hansaplast Brand Shares in OTC Healthcare by Sector by Value 2004-2005

Table 8 Beiersdorf AG: Hansaplast Regional Shares in OTC Healthcare by Sector by Value 2005

Appendices

Financial Summary

Table 9 Beiersdorf AG: Financial Summary 2001-2005

Company Background

Summary 2 Beiersdorf AG: Historical Development

Summary 3 Beiersdorf AG: Subsidiaries 2005

Summary 4 Beiersdorf AG: OTC Healthcare Brands 2005

Summary 5 Beiersdorf AG: Company Locations

Summary 6 Beiersdorf AG: Websites

OTC drugs

Beiersdorf Ag: OTC Healthcare

Price £195.00